Abstract:
Neurological diseases (NDs) are causing burgeoning burden to the patients, healthcare
sector and the entire society. Hundreds of millions of people are currently a ected by
various NDs worldwide and the number is increasing very rapidly. The most frequent
categories include Alzheimer's disease (AD), Parkinson's disease (PD), epilepsy, Multiple
sclerosis (MS), stroke and other cerebrovascular disorders, migraine and other
headache, malignant brain tumors such as Glioblastoma multiforme (GBM) etc. Despite
numerous research initiatives, preventive and therapeutic options for most of
these NDs still remain very limited. Taking AD as an example, fully e ective preventive
strategies are unavailable till now. Preventive measures usually comprise primary
prevention based on risk reducing by identifying in
uential factors and secondary prevention
through early detection and abatement of the disease at initial stage. But
the inadequate epidemiological knowledge of AD risk factors and absence of early premortem
accurate diagnosis has foiled AD prevention. However, better insight about
the co-occurrence of other neurological complications with AD can yield preventive
and therapeutic advancement. On the other hand, enhanced understanding about the
factors that impacts the response to the treatment could prolong the survival period.
For instance, GBM is such an ND with shorten survival period provided the rst line
treatment include brain surgery followed by chemotherapy and radiotherapy.
In this context, research initiatives to mitigate the information gap regarding how
the causative factors a ect the cell pathways altered in NDs and their comorbidities can
alleviate the disease burden. Availability of high throughput technologies including microarray
and next-generation sequencing (NGS) of tissue mRNA to analyse large-scale
transcriptomic data have excelled various bioinformatics methodologies as promising
tools in biomedical research eld. These approaches include di erential gene expression
analysis, protein-protein interactions (PPIs), gene ontology (GO), metabolic pathway
and regulatory factor analysis. Genetic inspection into the transcriptomic data through
these tools yields better insight into the molecular pathogenesis of any health condition
in junction with its causative factors and related complications. In addition to
this, the exponentially increasing amount of accessible biological data has made machine
learning techniques as promising means of discovering hidden genetic knowledge.
In this thesis, we presented bioinformatics and computational frameworks based on
transcriptomic data and machine learning based survival prediction models.
Description:
This Thesis is Submitted to the Department of Computer Science and Engineering , University of Rajshahi, Rajshahi, Bangladesh for The Degree of Master of Philosophy (MPhil)